Evaluation of Enzyme Inhibitors in Drug Discovery

A Guide for Medicinal Chemists and Pharmacologists

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry
Cover of the book Evaluation of Enzyme Inhibitors in Drug Discovery by Robert A. Copeland, Wiley
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Robert A. Copeland ISBN: 9781118540282
Publisher: Wiley Publication: January 31, 2013
Imprint: Wiley-Interscience Language: English
Author: Robert A. Copeland
ISBN: 9781118540282
Publisher: Wiley
Publication: January 31, 2013
Imprint: Wiley-Interscience
Language: English

Offers essential guidance for discovering and optimizing novel drug therapies

Using detailed examples, Evaluation of Enzyme Inhibitors in Drug Discovery equips researchers with the tools needed to apply the science of enzymology and biochemistry to the discovery, optimization, and preclinical development of drugs that work by inhibiting specific enzyme targets. Readers will applaud this book for its clear and practical presentations, including its expert advice on best practices to follow and pitfalls to avoid.

This Second Edition brings the book thoroughly up to date with the latest research findings and practices. Updates explore additional forms of enzyme inhibition and special treatments for enzymes that act on macromolecular substrates. Readers will also find new discussions detailing the development and application of the concept of drug-target residence time.

Evaluation of Enzyme Inhibitors in Drug Discovery begins by explaining why enzymes are such important drug targets and then examines enzyme reaction mechanisms. The book covers:

  • Reversible modes of inhibitor interactions with enzymes
  • Assay considerations for compound library screening
  • Lead optimization and structure-activity relationships for reversible inhibitors
  • Slow binding and tight binding inhibitors
  • Drug-target residence time
  • Irreversible enzyme inactivators

The book ends with a new chapter exploring the application of quantitative biochemical principles to the pharmacologic evaluation of drug candidates during lead optimization and preclinical development.

The Second Edition of Evaluation of Enzyme Inhibitors in Drug Discovery continues to offer a treatment of enzymology applied to drug discovery that is quantitative and mathematically rigorous. At the same time, the clear and simple presentations demystify the complex science of enzymology, making the book accessible to many fields— from pharmacology to medicinal chemistry to biophysics to clinical medicine.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Offers essential guidance for discovering and optimizing novel drug therapies

Using detailed examples, Evaluation of Enzyme Inhibitors in Drug Discovery equips researchers with the tools needed to apply the science of enzymology and biochemistry to the discovery, optimization, and preclinical development of drugs that work by inhibiting specific enzyme targets. Readers will applaud this book for its clear and practical presentations, including its expert advice on best practices to follow and pitfalls to avoid.

This Second Edition brings the book thoroughly up to date with the latest research findings and practices. Updates explore additional forms of enzyme inhibition and special treatments for enzymes that act on macromolecular substrates. Readers will also find new discussions detailing the development and application of the concept of drug-target residence time.

Evaluation of Enzyme Inhibitors in Drug Discovery begins by explaining why enzymes are such important drug targets and then examines enzyme reaction mechanisms. The book covers:

The book ends with a new chapter exploring the application of quantitative biochemical principles to the pharmacologic evaluation of drug candidates during lead optimization and preclinical development.

The Second Edition of Evaluation of Enzyme Inhibitors in Drug Discovery continues to offer a treatment of enzymology applied to drug discovery that is quantitative and mathematically rigorous. At the same time, the clear and simple presentations demystify the complex science of enzymology, making the book accessible to many fields— from pharmacology to medicinal chemistry to biophysics to clinical medicine.

More books from Wiley

Cover of the book Complex Macromolecular Architectures by Robert A. Copeland
Cover of the book Resolving Conflicts at Work by Robert A. Copeland
Cover of the book Cardiac Pacing, Defibrillation and Resynchronization by Robert A. Copeland
Cover of the book Non-ionizing Radiation Protection by Robert A. Copeland
Cover of the book Political Justice by Robert A. Copeland
Cover of the book Design and Analysis of Experiments in the Health Sciences by Robert A. Copeland
Cover of the book Media and Modernity by Robert A. Copeland
Cover of the book What Use is Sociology? by Robert A. Copeland
Cover of the book Autodesk Revit 2017 for Architecture by Robert A. Copeland
Cover of the book Munich 1919 by Robert A. Copeland
Cover of the book Turnaround Tools for the Teenage Brain by Robert A. Copeland
Cover of the book Animal Physiotherapy by Robert A. Copeland
Cover of the book Rick Sammon's Digital Photography Secrets by Robert A. Copeland
Cover of the book Lecture on Ethics by Robert A. Copeland
Cover of the book A Companion to the Anthropology of India by Robert A. Copeland
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy